BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33448720)

  • 1. Two Clonally Distinct B-Cell Lymphomas Reveal the Diagnosis of XLP1 in a Male Child and His Asymptomatic Male Relatives: Case Report and Review of the Literature.
    Iglesias Cardenas F; Agarwal AM; Vagher J; Maese L; Fluchel M; Afify Z
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):e1210-e1213. PubMed ID: 33448720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis.
    Meazza R; Tuberosa C; Cetica V; Falco M; Parolini S; Grieve S; Griffiths GM; Sieni E; Marcenaro S; Micalizzi C; Montin D; Fagioli F; Moretta A; Mingari MC; Moretta L; Notarangelo LD; Bottino C; Aricò M; Pende D
    J Allergy Clin Immunol; 2014 Dec; 134(6):1381-1387.e7. PubMed ID: 24985396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exon skipping caused by a complex structural variation in SH2D1A resulted in X-linked lymphoproliferative syndrome type 1.
    Wu L; Yang F; Wang J; Yang F; Liang M; Yang H
    Mol Genet Genomic Med; 2022 Mar; 10(3):e1873. PubMed ID: 35092357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease.
    Booth C; Gilmour KC; Veys P; Gennery AR; Slatter MA; Chapel H; Heath PT; Steward CG; Smith O; O'Meara A; Kerrigan H; Mahlaoui N; Cavazzana-Calvo M; Fischer A; Moshous D; Blanche S; Pachlopnik Schmid J; Latour S; de Saint-Basile G; Albert M; Notheis G; Rieber N; Strahm B; Ritterbusch H; Lankester A; Hartwig NG; Meyts I; Plebani A; Soresina A; Finocchi A; Pignata C; Cirillo E; Bonanomi S; Peters C; Kalwak K; Pasic S; Sedlacek P; Jazbec J; Kanegane H; Nichols KE; Hanson IC; Kapoor N; Haddad E; Cowan M; Choo S; Smart J; Arkwright PD; Gaspar HB
    Blood; 2011 Jan; 117(1):53-62. PubMed ID: 20926771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked Lymphoproliferative Disease Type 1 in a Patient With the p.Gly93Asp SH2D1A Gene Mutation and Hemophagocytic Lymphohistiocytosis.
    de la Varga-Martínez R; Mora-López F; García-Cuesta D; Garrastazul-Sánchez MP; Quintero S; Rodríguez C; Sampalo A
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e483-e485. PubMed ID: 28816794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Meningoencephalitis With Thrombotic Occlusive Vasculopathy in a Young EBV-Naïve Boy Is Associated With a Novel
    Steininger J; Rossmanith R; Geier CB; Leiss-Piller A; Thonhauser L; Weiss S; Hainfellner JA; Freilinger M; Schmidt WM; Eibl MM; Wolf HM
    Front Immunol; 2021; 12():747738. PubMed ID: 34987501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel nonsense mutation in SH2D1A in a patient with X-linked lymphoproliferative syndrome type 1: a case report.
    Lyu X; Guo Z; Li Y; Fan R; Song Y
    BMC Med Genet; 2018 Apr; 19(1):60. PubMed ID: 29649976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1.
    Marsh RA; Bleesing JJ; Chandrakasan S; Jordan MB; Davies SM; Filipovich AH
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1641-5. PubMed ID: 24923536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
    Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
    Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different Phenotypic Presentations of X-Linked Lymphoproliferative Disease in Siblings with Identical Mutations.
    Nademi Z; Radwan N; Rao K; Gilmour K; Worth A; Booth C
    J Clin Immunol; 2019 Jul; 39(5):523-526. PubMed ID: 31144249
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted sequencing identifies a novel SH2D1A pathogenic variant in a Chinese family: Carrier screening and prenatal genetic testing.
    Zhang JY; Chen SC; Chen YY; Li SY; Zhang LL; Shen YH; Chang CX; Xiang YQ; Huang HF; Xu CM
    PLoS One; 2017; 12(2):e0172173. PubMed ID: 28231257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic challenges for a novel SH2D1A mutation associated with X-linked lymphoproliferative disease.
    Torralba-Raga L; Tesi B; Chiang SCC; Schlums H; Nordenskjöld M; Horne A; Henter JI; Meeths M; Abdelhaleem M; Weitzman S; Bryceson Y
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28184. PubMed ID: 31994322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective.
    Panchal N; Booth C; Cannons JL; Schwartzberg PL
    Front Immunol; 2018; 9():666. PubMed ID: 29670631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemophagocytic lymphohistiocytosis in a patient with x-linked lymphoproliferative disease.
    Bird JA; McClain KL; Rosenblatt HM; Abramson SL; Hanson IC
    Allergy Asthma Proc; 2009; 30(4):458-62. PubMed ID: 19772767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new SH2D1A mutation in a female adult XLP disease with hemophagocytic lymphohistiocytosis and NK-cell leukemia.
    Liang JH; Zhu HY; Xu DM; Wang L; Wang Y; Qiao C; Wu YJ; Wang R; Li JY; Xu W
    Ann Hematol; 2019 Dec; 98(12):2829-2831. PubMed ID: 31758261
    [No Abstract]   [Full Text] [Related]  

  • 16. Familial hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease.
    Marsh RA; Filipovich AH
    Ann N Y Acad Sci; 2011 Nov; 1238():106-21. PubMed ID: 22129058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save lives.
    Sperl D; Benesch M; Urban C; Lackner H; Sovinz P; Speicher MR; Uhrig S; Schwarzbraun T; Schwinger W; zur Stadt U; Beutel K; Janka G; Scarpatetti M; Seidel MG
    Klin Padiatr; 2012 Oct; 224(6):386-9. PubMed ID: 23143765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: Report of five cases with three novel mutations and review of the literature.
    Jin YY; Zhou W; Tian ZQ; Chen TX
    Hum Immunol; 2016 Aug; 77(8):658-666. PubMed ID: 27288720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms.
    Sandlund JT; Shurtleff SA; Onciu M; Horwitz E; Leung W; Howard V; Rencher R; Conley ME
    Pediatr Blood Cancer; 2013 Sep; 60(9):E85-7. PubMed ID: 23589280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular characteristics of Chinese patients with X-linked lymphoproliferative syndrome type 1.
    An YF; Luo XB; Yang X; Wang J; Li L; Zhao XD
    Pediatr Blood Cancer; 2014 Nov; 61(11):2043-7. PubMed ID: 25044636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.